ITPA
ITPA (inosine triphosphatase, also known as HLC14-06-P, dJ794I6.3 and C20orf37) is a cytoplasmic pyrophosphatase that hydrolyses non-canonical purine nucleotides such as inosine triphosphate. It helps keep these nucleotides out of the RNA and DNA precursor pools. Browse Assay Genie's current range of ITPA research reagents below, or read on for the biology behind the target.
ITPA is a pyrophosphatase that hydrolyses the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP), 2'-deoxy-N-6-hydroxylaminopurine triphosphate (dHAPTP) and xanthosine 5'-triphosphate (XTP). Each is converted to its monophosphate derivative, releasing diphosphate. The enzyme does not distinguish between the deoxy and ribose forms of its substrates. By acting on these molecules, ITPA probably excludes non-canonical purines from RNA and DNA precursor pools. This prevents their incorporation into RNA and DNA and so avoids chromosomal lesions.
The human ITPA gene encodes an inosine triphosphate pyrophosphohydrolase that belongs to the HAM1 NTPase family. The protein is found in the cytoplasm and acts as a homodimer. Alternate splicing of the gene results in multiple transcript variants. Mouse and rat orthologs, both named Itpa, are recognised, which allows the enzyme to be studied in rodent systems.
Defects in the ITPA protein can result in inosine triphosphate pyrophosphorylase deficiency, which causes an accumulation of ITP in red blood cells. The gene has also been listed as C20orf37, and its earlier HGNC name was inosine triphosphatase (nucleoside triphosphate pyrophosphatase). Researchers studying nucleotide pool sanitation, purine metabolism and genome integrity use the ITPA gene and protein as a reference point for how cells handle aberrant nucleotides.
ITPA hydrolyses ITP, dITP, dHAPTP and XTP, making it a key enzyme for studying how non-canonical purines are removed from nucleotide pools.
By keeping non-canonical purines out of RNA and DNA precursor pools, ITPA helps avoid chromosomal lesions, a topic relevant to DNA damage studies.
ITPA deficiency causes ITP to accumulate in red blood cells, linking the enzyme to studies of erythrocyte purine metabolism.
ITPA is a homodimeric member of the HAM1 NTPase family, useful for comparative work on enzymes that act on non-canonical nucleotides.
ITPA is a pyrophosphatase that hydrolyses ITP, dITP, dHAPTP and XTP to their monophosphate derivatives. It probably excludes non-canonical purines from RNA and DNA precursor pools, preventing their incorporation into nucleic acids and avoiding chromosomal lesions.
ITPA is also known as HLC14-06-P, dJ794I6.3 and C20orf37, and as inosine triphosphate pyrophosphatase. Its earlier HGNC name was inosine triphosphatase (nucleoside triphosphate pyrophosphatase). Alternate splicing gives multiple transcript variants of the gene.
Defects in ITPA can cause inosine triphosphate pyrophosphorylase deficiency, with ITP accumulating in red blood cells. Orthologs named Itpa exist in mouse and rat; check the datasheet of any product for its validated reactivity.
Other nucleotide-metabolism enzymes and DNA-repair targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BY32; product specifications from Assay Genie datasheets.